BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Xiao YH, Liu DW, Li Q. Effects of drug serum of anti-fibrosis I herbal compound on calcium in hepatic stellate cell and its molecular mechanism. World J Gastroenterol 2005; 11(10): 1515-1520 [PMID: 15770729 DOI: 10.3748/wjg.v11.i10.1515]
URL: https://www.wjgnet.com/1007-9327/full/v11/i10/1515.htm
Number Citing Articles
1
Natalia Smith-Cortinez, Janette Heegsma, Masa Podunavac, Armen Zakarian, J. César Cardenas, Klaas Nico Faber. Novel Inositol 1,4,5-Trisphosphate Receptor Inhibitor Antagonizes Hepatic Stellate Cell Activation: A Potential Drug to Treat Liver FibrosisCells 2024; 13(9): 765 doi: 10.3390/cells13090765
2
Ding-Zhu Shen. A target role for mast cell in the prevention and therapy of hepatic fibrosisMedical Hypotheses 2008; 70(4): 760 doi: 10.1016/j.mehy.2007.07.042
3
Xingjun Liu, Han Hu, James Q. Yin. Therapeutic strategies against TGF‐β signaling pathway in hepatic fibrosisLiver International 2006; 26(1): 8 doi: 10.1111/j.1478-3231.2005.01192.x
4
Dan Xu, Yong Wu, Zhang-Xiu Liao, Hui Wang. Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in ratsPharmacological Research 2007; 55(4): 280 doi: 10.1016/j.phrs.2006.12.003
5
Mohamed El-Boshy E. Studies on Hepatoprotective Effect of Pentoxifylline on Ccl4 Induced Liver Fibrosis in Guinea PigsInternational Clinical Pathology Journal 2015; 1(5) doi: 10.15406/icpjl.2015.01.00021
6
Weihua Yin, Wei Zhang, Yanfang Zhu, Huihui Ni, Li Gong, Maoying Fu. miR‑219‑3p regulates the occurrence of hepatic fibrosis by targeting Smad2Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7480